Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127705861 | 12770586 | 1 | I | 20160907 | 20160922 | 20160922 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01890 | WESTWARD | OSMAN B,MAGA J,BAQUERO S. CASE REPORT: MANAGEMENT OF DIFFERENTIAL DIAGNOSIS AND TREATMENT OF SEVERE ANAPHYLAXIS IN THE SETTING OF SPINAL ANESTHESIA. JOURNAL OF CLINICAL ANESTHESIA 2016;35:145-149. | 58.00 | YR | F | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127705861 | 12770586 | 1 | PS | CEFAZOLIN | CEFAZOLIN | 1 | Intravenous (not otherwise specified) | 2 ML (20% OF THE TOTAL 2 G DOSE) OF A 0.2 MG/ML | 65047 | 2 | ML | ||||||||
| 127705861 | 12770586 | 2 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | |||||||||||
| 127705861 | 12770586 | 3 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | |||||||||||
| 127705861 | 12770586 | 4 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 2 | MG | |||||||||
| 127705861 | 12770586 | 5 | C | LIDOCAINE. | LIDOCAINE | 1 | Unknown | 0 | |||||||||||
| 127705861 | 12770586 | 6 | C | BUPIVACAINE. | BUPIVACAINE | 1 | Intravenous bolus | A SINGLE SHOT 2-ML (15 MG) | 0 | 15 | MG | ||||||||
| 127705861 | 12770586 | 7 | C | FENTANYL. | FENTANYL | 1 | Unknown | 0 | 25 | UG | |||||||||
| 127705861 | 12770586 | 8 | C | OXYGEN. | OXYGEN | 1 | Unknown | DELIVERED VIA FACEMASK AT 4 L/MIN | 0 | ||||||||||
| 127705861 | 12770586 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | |||||||||||
| 127705861 | 12770586 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127705861 | 12770586 | 1 | Product used for unknown indication |
| 127705861 | 12770586 | 2 | Product used for unknown indication |
| 127705861 | 12770586 | 3 | Product used for unknown indication |
| 127705861 | 12770586 | 4 | Product used for unknown indication |
| 127705861 | 12770586 | 5 | Anaesthesia |
| 127705861 | 12770586 | 6 | Product used for unknown indication |
| 127705861 | 12770586 | 7 | Product used for unknown indication |
| 127705861 | 12770586 | 8 | Product used for unknown indication |
| 127705861 | 12770586 | 9 | Product used for unknown indication |
| 127705861 | 12770586 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127705861 | 12770586 | OT |
| 127705861 | 12770586 | HO |
| 127705861 | 12770586 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127705861 | 12770586 | Anaphylactic shock | |
| 127705861 | 12770586 | Metabolic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |